Novartis has confimred that pharma jobs will be reallocated in 2014 in a continuation of the productivity drive that saved the firm $2.8bn (EUR2bn) last year.
Swiss newspaper NZZ am Sonntag reported that Novartis was looking to cut or transfer up to 4,000 jobs – approximately 6% of its global workforce – earlier this week.
Novartis spokeswoman Anja von Treskow told us the firm “intends to free up, prioritize and reallocate resources primarily in the pharmaceutical area,” adding it needs to increase its “flexibility, and be faster and more effective.”
She added: “This is part of our normal business operations and reflects our need to respond to a dynamically changing healthcare environment.”
Chosen excerpts by Job Market Monitor. Read the whole story at Novartis reallocating jobs as looks to drive productivity.
Related articles
- Novartis / To shuffle and cut jobs
- Novartis (Ciba Vision) / To cut 300 jobs with closure in Mississauga
- Layoffs in Pharmaceutical Industry / Due to Productivity Crisis in R&D ?
- Novartis to shuffle jobs to support product launches (news.yahoo.com)
Job Market Monitor 
With the latest development Novartis has acquired CoStim Pharmaceuticals. This would let the company help in developing monoclonal antibody drugs that enable a patient’s own immune system to better fight cancer.
Posted by prkralex | February 19, 2014, 2:30 am